ImmunoCellular Therapeutics’ Investigational New Drug Application for ICT-140 Allowed by the FDA

News   Jan 30, 2013

 
ImmunoCellular Therapeutics’ Investigational New Drug Application for ICT-140 Allowed by the FDA
 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE